Dynabeads™ Protein G for Immunoprecipitation
Dynabeads™ Protein G for Immunoprecipitation
Invitrogen™

Dynabeads™ Protein G for Immunoprecipitation

Dynabeads™ Protein G는 면역침강법에 sepharose나 agarose slurry 대신 사용할 수 있는 우수한 대응품입니다. 면역침강법에 Dynabeads™ Protein G를 사용하면,: 프로토콜 시간이자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량
10009D50 mL
10003D1 mL
10004D5 mL
카탈로그 번호 10009D
제품 가격(KRW)
-
수량:
50 mL
Dynabeads™ Protein G는 면역침강법에 sepharose나 agarose slurry 대신 사용할 수 있는 우수한 대응품입니다. 면역침강법에 Dynabeads™ Protein G를 사용하면,:
  • 프로토콜 시간이 30분으로 줄어듭니다.
  • 비특이적 결합으로 인한 배경 수준을 유의하게 없애줍니다.
  • 단백질을 손상없이 온전하게 유지합니다. 소중한 단백질에 물리적 스트레스가 가해지지 않습니다.

Dynabeads™ Protein G는 소규모 IgG 정화와 Ab 라벨링, 면역침강법(IP), 크로마틴 면역침강법(ChIP), 단백질 분리에 널리 사용됩니다. 자기 분리법은 신속하고 부드러워 표적 단백질에 가해지는 물리적 스트레스를 최소화합니다. 이러한 특징으로 긴 배양 시간 동안 프로테아제로 분해되거나 손상될 수 있는 불안정한 성분을 분리하고 농축시킬 수 있습니다. 원래 단백질 구조와 완전하고 큰 단백질 복합체 형태가 유지됩니다.

Dynabeads™는 표면에 protein G가 결합되어 있어 대부분의 포유류 면역글로불린(Ig)을 분리할 수 있습니다. 여러 종과 하위계열에 대한 결합력은 아래 이미지와 데이터에 있는 결합력 표를 참조하세요. 확보되는 Ig 양은 시작 샘플의 Ig 농도, 그 lg 유형과 소스에 따라 다릅니다.

이 제품은 재현성과 자동화 성능 등에서 Dynal의 높은 표준에 부합하여 분석 신뢰성을 높입니다.

장점 및 특징:
  • 컬럼, 원심분리 또는 시간이 많이 드는 샘플 전처리 과정이 필요없습니다.
  • 소규모 IgG 정제와 면역침강법에 아주 적합합니다.
  • 취급이 쉽고 프로토콜이 간편합니다.
  • 부드러운 처리 과정으로 단백질에 가해지는 물리적 스트레스를 최소화합니다.
  • 비드의 재조합 단백질 G에는 알부민 결합 부위가 없어 오염 단백질 동시 정제가 이루어지지 않습니다.
어플리케이션:
소규모 IgG 정제, 면역침강법(IP), 크로마틴 면역침강법(ChIP), 단백질 분리.

결합 성능:
확보되는 Ig 양은 시작 샘플의 Ig 농도에 따라 다릅니다. 100 μl Dynabeads Protein G는 시작 샘플 농도 20- 200 μg IgG ⁄ml에서 인간 lgG를 약 25- 30 μg 분리해 냅니다. Predominant Fc 결합으로 Ig 방향을 최적화합니다.

시작 샘플:
침, 혈장, 복수, 혈청, 조직 배양이나 하이브리도마 상층액 등이 시작 샘플이 될 수 있습니다.

추가 정보:Dynabeads™ Protein A 와 Protein G는 OEM으로도 구매 가능합니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
인증/적합성ISO9001 and ISO13485
농도30 mg/mL
설명Recombinant Protein G covalently bound to Dynabeads
직경(미터법)2.8 μm
용도(애플리케이션)Immunoprecipitation
용도(장비)KingFisher™ Sample Purification System, DynaMag™ magnets
형식Beads in suspension
고처리량 호환성High-throughput Compatible
리간드 유형Protein G
물질Polystyrene
순도 또는 품질 등급For Research Use Only
수량50 mL
유통 기한48 months from date of manufacture
배송 조건Ambient temperature
충분1000 Tests
표면 기능성Protein G
타겟Antibodies
균일성Monosized 2.8 mm (CV <5%)
제품라인Dynabeads
유형Superparamagnetic Beads
Unit SizeEach
구성 및 보관
Dynabeads Protein G are supplied in PBS, pH 7.4 w/0.01% Tween-20, 0.09% NaN3 Store at 2–8°C.

자주 묻는 질문(FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

인용 및 참조 문헌 (18)

인용 및 참조 문헌
Abstract
Characterization of human cytochrome P450s involved in the bioactivation of tri-ortho-cresyl phosphate (ToCP).
Authors:Reinen J, Nematollahi L, Fidder A, Vermeulen NP, Noort D, Commandeur JN
Journal:
PubMed ID:25706813
'Tri-ortho-cresyl phosphate (ToCP) is a multipurpose organophosphorus compound that is neurotoxic and suspected to be involved in aerotoxic syndrome in humans. It has been reported that not ToCP itself but a metabolite of ToCP, namely, 2-(ortho-cresyl)-4H-1,2,3-benzodioxaphosphoran-2-one (CBDP), may be responsible for this effect as it can irreversibly bind to human ... More
Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples.
Authors:Carter MD, Crow BS, Pantazides BG, Watson CM, DeCastro BR, Thomas JD, Blake TA, Johnson RC
Journal:
PubMed ID:23954929
'A high-throughput prioritization method was developed for use with a validated confirmatory method detecting organophosphorus nerve agent exposure by immunomagnetic separation high-performance liquid chromatography tandem mass spectrometry. A ballistic gradient was incorporated into this analytical method to profile unadducted butyrylcholinesterase (BChE) in clinical samples. With Zhang et al.''s Z'' factor ... More
Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.
Authors:Orba Y, Suzuki T, Makino Y, Kubota K, Tanaka S, Kimura T, Sawa H,
Journal:J Biol Chem
PubMed ID:19903823
Large T antigen (TAg) of the human polyomavirus JC virus (JCV) possesses DNA binding and helicase activities, which, together with various cellular proteins, are required for replication of the viral genome. We now show that JCV-infected cells expressing TAg accumulate in the G(2) phase of the cell cycle as a ... More
An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.
Authors:Pantazides BG, Watson CM, Carter MD, Crow BS, Perez JW, Blake TA, Thomas JD, Johnson RC
Journal:
PubMed ID:24604326
Organophosphorus nerve agent (OPNA) adducts to butyrylcholinesterase (BChE) can be used to confirm exposure in humans. A highly accurate method to detect G- and V-series OPNA adducts to BChE in 75 µL of filtered blood, serum, or plasma has been developed using immunomagnetic separation (IMS) coupled with liquid chromatography tandem mass ... More
High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.
Authors:Whiteaker JR, Zhao L, Frisch C, Ylera F, Harth S, Knappik A, Paulovich AG
Journal:
PubMed ID:24568200
High-affinity antibodies binding to linear peptides in solution are a prerequisite for performing immuno-MRM, an emerging technology for protein quantitation with high precision and specificity using peptide immunoaffinity enrichment coupled to stable isotope dilution and targeted mass spectrometry. Recombinant antibodies can be generated from appropriate libraries in high-throughput in an ... More